S. Stutvoet
Galapagos NVPoster Author Of 1 e-Poster
A4597 - Rationale, Design and Objectives of Two Phase III, Randomised, Placebo-Controlled Studies of GLPG1690, a Novel Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (ISABELA 1 and 2)
Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C34 - ILD AND IPF: CLINICAL AND MECHANISTIC STUDIES